MedTrace Logo

Foresee Home for Monitoring Age Related Macular Degeneration (AMD)

NCT01010997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2012-07-31

No results posted yet for this study

Summary

The FORESEE HOME is intended for the early detection of central and paracentral irregularities (abnormalities) in the visual field, most commonly associated with AMD. However, the device has ability to detect the development of the lesion post treatment and therefore to asses in determination of the next treatment.

Conditions

  • Age Related Macular Degeneration

Interventions

DEVICE

Foresee Home

using the Foresee home device

Sponsors & Collaborators

  • Notal Vision Ltd.

    lead INDUSTRY

Principal Investigators

  • Eliezer Kraus, MD · Naharia Hospital

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01010997 on ClinicalTrials.gov